ABCL - Abcellera Biologics Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ABCL (1703057)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear

5 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2020-12-15
ABCLThiel PeterDirP - Purchase$20.00+3,000,00024,660-101%+$60,000,000
D
2020-12-15
ABCLMontalbano John S.DirP - Purchase$20.00+25,00025,000New+$500,000
D
2020-12-15
ABCLLecault VeroniqueCOOP - Purchase$20.00+23,0009,496,2180%+$460,000
D
2020-12-15
ABCLHayden Michael RDirP - Purchase$20.00+73,6651,221,642+6%+$1,473,300
D
2020-12-15
ABCLStimart TrynGCP - Purchase$20.00+500500New+$10,000

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top